Hyperthyroidism After Allogeneic Hematopoietic Stem Cell Transplantation: A Report of Four Cases
Overview
Pediatrics
Authors
Affiliations
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for many hematological disorders, primary immunodeficiencies, and metabolic disorders. Thyroid dysfunction is one of the frequently seen complications of HSCT. However, hyperthyroidism due to Graves' disease, autoimmune thyroiditis, and thyrotoxicosis are rare. Herein, we report a series of 4 patients who were euthyroid before HSCT but developed hyperthyroidism (3 of them developed autoimmune thyroid disease) after transplantation.
Cattoni A, Molinari S, Riva B, Di Marco S, Adavastro M, Faraguna M Front Endocrinol (Lausanne). 2023; 13:1064146.
PMID: 36619560 PMC: 9811586. DOI: 10.3389/fendo.2022.1064146.
Thyrotoxicosis after unrelated cord blood transplantation for adults.
Konuma T, Tomonari A, Ooi J, Nagayama H, Kawakita T, Kato S Ann Hematol. 2022; 102(3):673-676.
PMID: 36527457 DOI: 10.1007/s00277-022-05068-3.
Ge J, Wang J, Liu H, Wan R, Yao X Acta Endocrinol (Buchar). 2022; 18(2):238-240.
PMID: 36212265 PMC: 9512369. DOI: 10.4183/aeb.2022.238.
Late Endocrine Effects after Stem Cell Transplant in a Young Girl with Griscelli Syndrome.
Mencher S, Tamborlane W, Patel A Case Rep Pediatr. 2022; 2021:9981306.
PMID: 34987878 PMC: 8723881. DOI: 10.1155/2021/9981306.
Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation.
Buxbaum N, Pavletic S Front Immunol. 2020; 11:2017.
PMID: 32983144 PMC: 7479824. DOI: 10.3389/fimmu.2020.02017.